AssetMark Inc’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

AssetMark Inc’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40	Closed	-$9K	–	1607
2021 Q1	$9K	Hold	40	–	–	﹤0.01%	949
2020 Q4	$5K	Hold	40	–	–	﹤0.01%	1044
2020 Q3	$4K	Buy	+40	New	+$4.6K	﹤0.01%	1028
2020 Q2	–	Sell	-195	Closed	-$17K	–	1497
2020 Q1	$17K	Buy	+195	New	+$20.6K	﹤0.01%	905

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

AssetMark Inc's GWPH Position: Q2 2021 in Review

AssetMark Inc sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 40 shares — an estimated $9K sold.

AssetMark Inc first reported a position in GWPH in Q1 2020 and held it in 4 quarters. The position peaked at $17K in Q1 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

AssetMark Inc reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
AssetMark Inc sold 40 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $9K.
AssetMark Inc first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 4 quarters.
AssetMark Inc's GW Pharmaceuticals Plc American Depositary Shares position peaked at $17K in Q1 2020.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on AssetMark Inc's 13F filing for Q2 2021, filed 16 Aug 2021.